HENNEMAN JOHN B III
SEC insider (Form 3/4/5 filer). CIK 0001187572. Director at Anika Therapeutics, Inc. (ANIK) and 3 other issuers. 9 reported Form 4/5 transactions since Sep 2024; latest on Jun 18, 2026. Located in LEWISVILLE, TX.
Companies HENNEMAN JOHN B III has filed insider reports for
- Anika Therapeutics, Inc. (ANIK): Director
- Aprea Therapeutics, Inc. (APRE): Director
- Orthofix Medical Inc. (OFIX): Director
- R1 RCM Inc. /DE (RCM): Director
HENNEMAN JOHN B III
CIK: 0001187572
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- Jun 18, 2026ANIK
Anika Therapeutics, Inc.
AwardDirect10.4K shares- - Jun 16, 2026APRE
Aprea Therapeutics, Inc.
AwardDirect3.1K shares- - Jun 10, 2026OFIX
Orthofix Medical Inc.
AwardDirect15K shares- - May 7, 2026OFIX
Orthofix Medical Inc.
PurchaseDirect5K shares at avg. $12.26$61K - May 1, 2026ANIK
Anika Therapeutics, Inc.
PurchaseDirect5K shares at avg. $14.66$73K - Jun 20, 2025ANIK
Anika Therapeutics, Inc.
AwardDirect14.2K shares- - Jun 18, 2025OFIX
Orthofix Medical Inc.
AwardDirect18.8K shares- - Jun 5, 2025APRE
Aprea Therapeutics, Inc.
AwardDirect1K shares- - Nov 19, 2024RCM
R1 RCM Inc. /DE
DispositionDirect87.8K shares at avg. $14.30$1.3M
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 18, 2026 |  ANIK Anika Therapeutics, Inc. | Award | 10,402 | - | $0 | Direct |
| Jun 16, 2026 |  APRE Aprea Therapeutics, Inc. | Award | 3,135 | - | $0 | Direct |
| Jun 10, 2026 |  OFIX Orthofix Medical Inc. | Award | 14,965 | - | $0 | Direct |
| May 7, 2026 | OFIX Orthofix Medical Inc. | Purchase | 5,000 | $12.26 | $61,295 | Direct |
| May 1, 2026 | ANIK Anika Therapeutics, Inc. | Purchase | 5,000 | $14.66 | $73,320 | Direct |
| Jun 20, 2025 | ANIK Anika Therapeutics, Inc. | Award | 14,164 | - | - | Direct |
| Jun 18, 2025 | OFIX Orthofix Medical Inc. | Award | 18,841 | - | - | Direct |
| Jun 5, 2025 | APRE Aprea Therapeutics, Inc. | Award | 1,045 | - | - | Direct |
| Nov 19, 2024 |  RCM R1 RCM Inc. /DE | Disposition | 87,765 | $14.30 | $1,255,040 | Direct |
1-9 of 9 transactions